Literature DB >> 7989862

Distribution of angiotensin II receptors in rat and human adipocytes.

D L Crandall1, H E Herzlinger, B D Saunders, D C Armellino, J G Kral.   

Abstract

Angiotensin II (AII) receptor binding assays were performed in rat adipocytes from three separate anatomic depots. Fat cells were isolated by collagenase digestion, and plasma membranes were prepared from the epididymal, mesenteric, and retroperitoneal fat depots of male Sprague-Dawley rats at 100 days of age. Binding of 125I-labeled [Sar1,Ile8]AII was rapid, saturable, and specific in membranes from all depots, identifying a receptor with a similar affinity of approximately 1 nM. Site-associated differences in receptor number were observed, with epididymal and mesenteric fat cell membranes exhibiting significantly more receptors than retroperitoneal fat cells when binding was expressed per unit of membrane protein. When corrected for cell volume, the number of receptors per cell ranked epididymal > retroperitoneal > mesenteric. Inhibitory constants for the peptide agonists AII and AIII and the peptide antagonist [Sar1,Ala8]AII indicated similar affinities in all three depots. Because the receptor has been classified pharmacologically into two subtypes, the AT1 selective antagonist losartan, and the AT2 selective antagonist PD 123,319 were used to classify the adipocyte receptor, indicating an AT1 subtype with an affinity for losartan in the mesenteric and retroperitoneal adipocytes that was significantly greater than the epididymal. Similar studies were performed in adipocyte membranes obtained from human omental and subcutaneous adipose tissue, revealing the presence of an AII receptor in both depots with an affinity of approximately 10 nM for losartan. These data indicate site-specific differences in AII receptor number in fat cell membranes from rats and the existence of human adipocyte AII receptors, suggesting that the adipocyte is significant for the peripheral metabolism of components of the renin-angiotensin system.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7989862

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  12 in total

Review 1.  A critical review of the evidence supporting aldosterone in the etiology and its blockade in the treatment of obesity-associated hypertension.

Authors:  J B Byrd; R D Brook
Journal:  J Hum Hypertens       Date:  2013-05-23       Impact factor: 3.012

Review 2.  The impacts of obesity on the cardiovascular and renal systems: cascade of events and therapeutic approaches.

Authors:  Zohreh Soltani; Vaughn Washco; Stephen Morse; Efrain Reisin
Journal:  Curr Hypertens Rep       Date:  2015-02       Impact factor: 5.369

3.  Long-term angiotensin II AT1 receptor inhibition produces adipose tissue hypotrophy accompanied by increased expression of adiponectin and PPARgamma.

Authors:  Stefan Zorad; Jing-tao Dou; Julius Benicky; Daniel Hutanu; Katarina Tybitanclova; Jin Zhou; Juan M Saavedra
Journal:  Eur J Pharmacol       Date:  2006-09-09       Impact factor: 4.432

Review 4.  The intricacies of the renin-angiotensin-system in metabolic regulation.

Authors:  Erin B Bruce; Annette D de Kloet
Journal:  Physiol Behav       Date:  2016-11-22

5.  Deficiency of angiotensin type 1a receptors in adipocytes reduces differentiation and promotes hypertrophy of adipocytes in lean mice.

Authors:  Kelly Putnam; Frederique Batifoulier-Yiannikouris; Kalyani G Bharadwaj; Eboni Lewis; Michael Karounos; Alan Daugherty; Lisa A Cassis
Journal:  Endocrinology       Date:  2012-08-23       Impact factor: 4.736

Review 6.  The adipose renin-angiotensin system: role in cardiovascular disease.

Authors:  Sean Thatcher; Frederique Yiannikouris; Manisha Gupte; Lisa Cassis
Journal:  Mol Cell Endocrinol       Date:  2009-04-29       Impact factor: 4.102

7.  Comparison of circulating and local adipose tissue renin-angiotensin system in normotensive and hypertensive obese subjects.

Authors:  E Faloia; C Gatti; M A Camilloni; B Mariniello; C Sardu; G G M Garrapa; F Mantero; G Giacchetti
Journal:  J Endocrinol Invest       Date:  2002-04       Impact factor: 4.256

8.  AT1 receptor blockade alters nutritional and biometric development in obesity-resistant and obesity-prone rats submitted to a high fat diet.

Authors:  Pauline M Smith; Charles C T Hindmarch; David Murphy; Alastair V Ferguson
Journal:  Front Psychol       Date:  2014-07-29

9.  Angiotensin II signaling in human preadipose cells: participation of ERK1,2-dependent modulation of Akt.

Authors:  Natalia Dünner; Carolina Quezada; F Andrés Berndt; José Cánovas; Cecilia V Rojas
Journal:  PLoS One       Date:  2013-10-02       Impact factor: 3.240

Review 10.  Role of the Renin-Angiotensin-Aldosterone System beyond Blood Pressure Regulation: Molecular and Cellular Mechanisms Involved in End-Organ Damage during Arterial Hypertension.

Authors:  Natalia Muñoz-Durango; Cristóbal A Fuentes; Andrés E Castillo; Luis Martín González-Gómez; Andrea Vecchiola; Carlos E Fardella; Alexis M Kalergis
Journal:  Int J Mol Sci       Date:  2016-06-23       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.